AVDEX | VGTSX | AVDEX / VGTSX | |
Total Expense Ratio | 0.23 | 0.17 | 135% |
Annual Report Gross Expense Ratio | 0.23 | 0.17 | 135% |
Fund Existence | 6 years | 29 years | - |
Gain YTD | 27.234 | 21.815 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 411M | 526B | 0% |
Annual Yield % from dividends | 2.78 | 2.65 | 105% |
Returns for 1 year | 21.53 | 16.24 | 133% |
Returns for 3 years | 68.85 | 47.30 | 146% |
Returns for 5 years | 74.27 | 40.72 | 182% |
Returns for 10 years | N/A | 69.71 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 59.25 | 2.11 | +3.68% |
ProShares Ultra Nasdaq Biotechnology | |||
FCFY | 26.60 | N/A | N/A |
First Trust S&P 500 Div Fr CA Flw ETF | |||
JANM | 32.22 | -0.01 | -0.04% |
FT Vest U.S. Eq Max Buffr ETF - Jan | |||
FDEC | 48.28 | -0.09 | -0.19% |
FT Vest US Equity Buffer ETF Dec | |||
FTXO | 35.56 | -0.52 | -1.44% |
First Trust Nasdaq Bank ETF |